Kathy Sherwood - Inspire Medical Senior Access
| INSP Stock | USD 186.19 1.42 0.77% |
Executive
Kathy Sherwood is Senior Access of Inspire Medical Systems
| Address | 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 |
| Phone | 844 672 4357 |
| Web | https://www.inspiresleep.com |
Inspire Medical Management Efficiency
The company has return on total asset (ROA) of 0.0118 % which means that it generated a profit of $0.0118 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0533 %, meaning that it created $0.0533 on every $100 dollars invested by stockholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/22/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 11/22/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MPH MD | Inari Medical | N/A | |
| Nicholas Corcoran | TransMedics Group | 41 | |
| Pritesh Shah | Novocure | 46 | |
| Leverne Marsh | DexCom Inc | N/A | |
| Jason Mills | Penumbra | N/A | |
| Mark MS | Outset Medical | 67 | |
| Jane Rady | Glaukos Corp | 76 | |
| Shacey Petrovic | Insulet | 51 | |
| Frank Leonard | Novocure | N/A | |
| Ben Tompkins | Penumbra | N/A | |
| Paul Koehn | Inari Medical | 61 | |
| Wilhelmus Groenhuysen | Novocure | 66 | |
| Michele Allegretto | Glaukos Corp | N/A | |
| MBA MD | Novocure | 51 | |
| MD FACS | Glaukos Corp | N/A | |
| Prem Singh | Insulet | 47 | |
| John Brottem | Outset Medical | 49 | |
| Elizabeth Gasser | Tandem Diabetes Care | 48 | |
| Tom Fox | Tandem Diabetes Care | N/A | |
| David Esq | Tandem Diabetes Care | 54 | |
| Susan Goodman | TransMedics Group | N/A | |
Management Performance
| Return On Equity | 0.0533 | ||||
| Return On Asset | 0.0118 |
Inspire Medical Systems Leadership Team
Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgia GarinoisMelenikiotou, Independent Director | ||
| Megan CPA, Director Reporting | ||
| Timothy Herbert, President, Chief Executive Officer, Director | ||
| Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources | ||
| Martin Abrams, Vice Experience | ||
| John Rondoni, Chief Officer | ||
| Shawn McCormick, Independent Director | ||
| Ivan Lubogo, Senior Sales | ||
| Marilyn Nelson, Independent Chairman of the Board | ||
| Jerry Griffin, Independent Director | ||
| Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary | ||
| Melissa Mann, Chief Officer | ||
| Philip Ebeling, Chief Operating Officer | ||
| Ezgi Yagci, Vice Relations | ||
| Andreas Henke, Executive Europe | ||
| Casey Tansey, Independent Director | ||
| Richard Buchholz, Chief Financial Officer | ||
| Kathy Sherwood, Senior Access | ||
| Gary Ellis, Independent Director | ||
| Carlton Weatherby, Chief Officer | ||
| Randall Ban, Senior Vice President Global Sales and Marketing | ||
| Dana Mead, Independent Director | ||
| Shelley Broader, Independent Director | ||
| Bryan JD, General VP | ||
| Georgia Melenikiotou, Independent Director | ||
| MD FAAOS, Chief Officer |
Inspire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0533 | ||||
| Return On Asset | 0.0118 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.15 B | ||||
| Shares Outstanding | 29.97 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 98.06 % | ||||
| Number Of Shares Shorted | 1.95 M | ||||
| Price To Earning | 15.29 X |
Pair Trading with Inspire Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Inspire Stock
| 0.69 | DXCM | DexCom Inc | PairCorr |
| 0.59 | LH | Laboratory | PairCorr |
| 0.57 | GH | Guardant Health | PairCorr |
| 0.56 | VREX | Varex Imaging Corp | PairCorr |
| 0.45 | EW | Edwards Lifesciences Corp | PairCorr |
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.